NEW YORK (360Dx) – Qiagen said today that it has signed a non-exclusive partnership deal with Tecan Group to improve the processing of Qiagen's QuantiFeron-TB Gold Plus (QFT-Plus) diagnostic test.

Specifically, the companies are working together to standardize and automate the manual steps in liquid handling for the aliquoting of QFT-Plus samples using Tecan's Fluent laboratory automation workstation and Lithium Heparin single-tube workflow.